BioTech News and Headlines

Midlife Activity Linked to Men’s Hip Fracture Risk
NewsJan 26, 2026

Midlife Activity Linked to Men’s Hip Fracture Risk

A new longitudinal study in the Archives of Osteoporosis links midlife physical activity and body‑mass index (BMI) to hip‑fracture risk in men five decades later. Researchers analyzed thousands of participants from the NOREPOS cohort, finding that higher activity levels during...

By Bioengineer.org
Merck Backs Off Revolution After Failing To Agree on Price: WSJ
NewsJan 26, 2026

Merck Backs Off Revolution After Failing To Agree on Price: WSJ

Merck and Revolution Medicines ended acquisition talks after failing to agree on a purchase price, with proposals hovering between $28 billion and $32 billion. The biotech’s lead drug, daraxonrasib, has generated strong early‑stage data and earned an FDA priority voucher, making it...

By BioSpace
UK Medicines Agency Seized 20M Illegal Drugs Last Year, Including GLP-1s
NewsJan 26, 2026

UK Medicines Agency Seized 20M Illegal Drugs Last Year, Including GLP-1s

Britain’s Medicines and Healthcare products Regulatory Agency (MHRA) reported seizing nearly 20 million doses of illegally traded medicines in 2025, valued at roughly £200 million. The haul included a large share of GLP‑1 agonists, which have surged in demand for obesity and...

By Endpoints News
COPD Patients Will Get Access to Dupixent via NHS
NewsJan 26, 2026

COPD Patients Will Get Access to Dupixent via NHS

The UK’s health technology assessment agency NICE has recommended Sanofi‑Regeneron’s Dupixent for adults with eosinophilic, uncontrolled COPD, making it the first targeted biologic for the disease. Approved in September 2024, the IL‑4/IL‑13 inhibitor is prescribed alongside standard LABA/LAMA ±ICS therapy...

By pharmaphorum
Genmab Halts Enrollment for Cancer Drug From ProfoundBio Buyout
NewsJan 26, 2026

Genmab Halts Enrollment for Cancer Drug From ProfoundBio Buyout

Genmab announced it has stopped enrolling patients in an early‑stage trial of a cancer candidate acquired from ProfoundBio. The drug was part of Genmab’s $1.8 billion purchase of the US‑China biotech firm. The pause comes shortly after the acquisition closed, raising...

By Endpoints News
Tracking Corvid Vocalizations with Miniature Tech
NewsJan 26, 2026

Tracking Corvid Vocalizations with Miniature Tech

Researchers published a study in *Animal Cognition* demonstrating that ultra‑light, low‑impact tags can record high‑resolution vocalizations from free‑living corvids. The tags captured real‑time calls and associated body language, revealing distinct vocal patterns for kin versus strangers. Findings highlight corvids' sophisticated...

By Bioengineer.org
Analyzing Risk Factors in Hip Dysplasia via Ultrasound
NewsJan 26, 2026

Analyzing Risk Factors in Hip Dysplasia via Ultrasound

A recent clinical study leveraged neonatal ultrasound to pinpoint risk factors for developmental hip dysplasia (DDH). Researchers correlated specific sonographic markers with maternal BMI, genetic predisposition, and biomechanical variables. The analysis demonstrated that early, standardized imaging can markedly lower the...

By Bioengineer.org
Introducing the Sunday Times Tech 100: Life Sciences Part 1
NewsJan 26, 2026

Introducing the Sunday Times Tech 100: Life Sciences Part 1

The Sunday Times Tech 100 list shows that 23 of the 100 fastest‑growing UK private tech firms operate in life sciences, underscoring the sector’s momentum. The list aggregates £3.7 billion in revenue and 23,100 jobs, with a focus this week on five...

By pharmaphorum
Early Mortality Risks in Chinese Acute Leukemia Kids
NewsJan 26, 2026

Early Mortality Risks in Chinese Acute Leukemia Kids

A recent multicenter study of 1,842 Chinese children with acute leukemia identified several factors that double early‑mortality risk within 30 days of diagnosis. High‑risk features included age under one year, severe hyperleukocytosis, and delayed initiation of induction chemotherapy beyond 48...

By Bioengineer.org
Gender Differences in Anxiety and Depression in Mice
NewsJan 26, 2026

Gender Differences in Anxiety and Depression in Mice

A recent pre‑clinical study reveals pronounced gender differences in anxiety and depression phenotypes among laboratory mice. Female mice displayed significantly higher anxiety‑like behavior and depressive‑like immobility, while male mice showed milder responses under identical stress protocols. Hormonal profiling linked elevated...

By Bioengineer.org
From Detection to Prevention: How Sponsored Testing Can Transform Patient Outcomes
NewsJan 26, 2026

From Detection to Prevention: How Sponsored Testing Can Transform Patient Outcomes

Diagnostic testing is evolving from a purely detection tool to a preventive strategy, especially in Canada where provincial coverage varies. Pharmaceutical sponsors are launching paid testing programs that eliminate cost barriers, granting patients access to advanced risk‑identification assays for conditions...

By BioPharma Dive
The Crucial Role of Raw Material Selection for Success in Cell Therapy Manufacturing
NewsJan 26, 2026

The Crucial Role of Raw Material Selection for Success in Cell Therapy Manufacturing

Cell therapy’s promise hinges on manufacturing consistency, which is driven by the quality of raw (ancillary) materials such as media, cytokines, scaffolds, and disposables. Variability in these inputs can cause fluctuations in cell potency, safety, and regulatory compliance, especially when...

By BioPharma Dive
Granzyme B-Mimic Nanozyme Targets Cancer Cells
NewsJan 26, 2026

Granzyme B-Mimic Nanozyme Targets Cancer Cells

Researchers have engineered a granzyme B‑mimic nanozyme that selectively attacks cancer cells by replicating the proteolytic activity of the immune‑system enzyme granzyme B. Laboratory tests show the nanozyme cleaves tumor‑specific membrane proteins, triggering apoptosis while sparing healthy tissue. In mouse...

By Bioengineer.org
Streamlining ACMG Variant Classifications with BIAS-2015
NewsJan 26, 2026

Streamlining ACMG Variant Classifications with BIAS-2015

The study by Eisenhart, Brickey and Nadon introduces BIAS‑2015 v2.1.1, a machine‑learning algorithm designed to automate ACMG variant classifications. Benchmarking against the FDA‑approved eRepo dataset shows the tool achieves accuracy comparable to the gold‑standard reference. By learning from previously classified variants,...

By Bioengineer.org
Long-Term Crop Diversity Boosts Profit, Biodiversity, Ecosystems
NewsJan 26, 2026

Long-Term Crop Diversity Boosts Profit, Biodiversity, Ecosystems

A recent study finds that farms practicing long‑term crop diversity see higher profit margins, increased biodiversity, and stronger ecosystem services. Over a decade, diversified rotations reduced input costs by up to 15% while boosting yields of staple crops. Soil health...

By Bioengineer.org
Exploring Incentives for Buprenorphine Treatment in Family Medicine
NewsJan 26, 2026

Exploring Incentives for Buprenorphine Treatment in Family Medicine

The article examines emerging financial and regulatory incentives aimed at expanding buprenorphine prescribing within family medicine practices. It highlights federal grant programs, revised reimbursement structures, and streamlined waiver processes that lower barriers for primary‑care clinicians. The piece also discusses how...

By Bioengineer.org
Stress Effects on Learning and Memory in Cichlids
NewsJan 26, 2026

Stress Effects on Learning and Memory in Cichlids

Recent laboratory studies reveal that acute and chronic stress markedly diminish learning speed and memory retention in several cichlid species. Researchers measured cortisol spikes and employed maze navigation and color‑association tasks, finding up to a 40% performance drop under stress....

By Bioengineer.org
LncRNA PVT1 Influences Endothelial Function in DVT
NewsJan 26, 2026

LncRNA PVT1 Influences Endothelial Function in DVT

Researchers have identified the long non‑coding RNA PVT1 as a key regulator of endothelial function in deep vein thrombosis (DVT). In patient‑derived vein samples, PVT1 expression is markedly elevated, correlating with reduced nitric oxide bioavailability and heightened inflammatory signaling. In...

By Bioengineer.org
Environmental Exposome’s Role in Heart Failure Risk
NewsJan 26, 2026

Environmental Exposome’s Role in Heart Failure Risk

A new nationwide study finds that cumulative environmental exposures—collectively known as the exposome—significantly raise the risk of heart failure. By integrating air‑pollution data, chemical toxin records, and lifestyle factors with electronic health records of over 1.2 million patients, researchers quantified a...

By Bioengineer.org
Peptide Protects Dopaminergic Neurons in Parkinson’s Model
NewsJan 26, 2026

Peptide Protects Dopaminergic Neurons in Parkinson’s Model

Researchers led by Choe have demonstrated that a nine‑amino‑acid peptide derived from the plant protein osmotin can protect dopaminergic neurons in a mouse model of Parkinson's disease. The peptide attenuated α‑synuclein‑ and MPTP‑induced glial activation, reducing neuroinflammatory cytokine levels. Histological...

By Bioengineer.org
To Accelerate Rare Disease Progress, Take a Sandbox Approach
NewsJan 26, 2026

To Accelerate Rare Disease Progress, Take a Sandbox Approach

A sandbox framework is proposed to overhaul rare‑disease drug development, allowing regulators, sponsors, patients and academics to collaborate in real time. The model groups therapies into small‑molecule, biologic and complex sandboxes, enabling a continuous IND that spans Phase 1‑3 and eliminates...

By BioSpace
Energy Devices for Acne in Skin of Color
NewsJan 26, 2026

Energy Devices for Acne in Skin of Color

Energy‑based devices such as lasers, intense pulsed light (IPL) and radio‑frequency are increasingly used to treat acne in patients with darker skin tones. Recent clinical trials show that long‑pulse Nd:YAG lasers and low‑fluence fractional lasers reduce inflammatory lesions while minimizing...

By Bioengineer.org
3D Printed Polymers Mimic Atherosclerotic Blood Vessels’ Properties
NewsJan 26, 2026

3D Printed Polymers Mimic Atherosclerotic Blood Vessels’ Properties

Researchers have created 3D‑printed polymers that accurately mimic the mechanical behavior of atherosclerotic blood vessels, addressing a long‑standing gap in surgical training models. By integrating UV‑induced and hydrolysis‑induced degradation, the materials can evolve from healthy‑like compliance to plaque‑like brittleness, offering...

By Bioengineer.org
Zonal Endothelial Cell Diversity Drives Renal Vascular Growth
NewsJan 26, 2026

Zonal Endothelial Cell Diversity Drives Renal Vascular Growth

Researchers have uncovered that endothelial cells in the kidney exhibit distinct zonal identities, each contributing uniquely to renal vascular growth. Using single‑cell RNA sequencing, the team mapped spatially resolved endothelial subpopulations and identified zone‑specific signaling pathways that promote angiogenesis. Functional...

By Bioengineer.org
Exploring CDPK Genes in Liriodendron Chinense Under Stress
NewsJan 25, 2026

Exploring CDPK Genes in Liriodendron Chinense Under Stress

Researchers have catalogued the calcium‑dependent protein kinase (CDPK) gene family in Liriodendron chinense, a prized ornamental and timber species. Twelve CDPK genes were identified, and transcriptomic profiling showed distinct up‑regulation under drought, salinity, and cold stress. Promoter analyses uncovered multiple...

By Bioengineer.org
Opioid Treatment’s Effects on Jail Mental Health Services
NewsJan 25, 2026

Opioid Treatment’s Effects on Jail Mental Health Services

A growing number of correctional facilities are integrating opioid agonist treatment (OAT) into their mental health services, aiming to curb overdose deaths and improve psychiatric outcomes among inmates. Recent pilot programs report a 30% drop in emergency psychiatric visits and...

By Bioengineer.org
Support for FDA Action on Menopausal Hormone Therapy
NewsJan 25, 2026

Support for FDA Action on Menopausal Hormone Therapy

The U.S. Food and Drug Administration announced a new regulatory push targeting menopausal hormone therapy (MHT), proposing stricter labeling requirements and heightened post‑market surveillance. The agency highlighted recent safety data linking certain formulations to increased cardiovascular and breast cancer risks,...

By Bioengineer.org
Nature: "Sidewinder" Tech a Leap Forward in DNA Synthesis
NewsJan 25, 2026

Nature: "Sidewinder" Tech a Leap Forward in DNA Synthesis

Nature has published a breakthrough DNA‑synthesis method called Sidewinder, which employs three‑way junctions instead of the traditional two‑way structures. This design lets researchers write DNA sequences from scratch, as demonstrated by assembling the full coding region of apolipoprotein E. Sidewinder promises...

By pharmaphorum
Enzyme‐Activated Programmable Theranostic Platform for Spatiotemporal Imaging of Intracellular MicroRNA and On‐Demand Manipulation‐Mediated Therapy
NewsJan 25, 2026

Enzyme‐Activated Programmable Theranostic Platform for Spatiotemporal Imaging of Intracellular MicroRNA and On‐Demand Manipulation‐Mediated Therapy

Researchers have engineered a cerium‑based metal‑organic framework (Ce‑MOF) loaded with DNA hairpins that responds to intracellular APE1 and miRNA‑21. The dual activation triggers a hybridization chain reaction, producing a Cy3‑Cy5 FRET signal for spatiotemporal imaging of miRNA expression in living...

By Small (Wiley)
Nanoengineering‐Based Strategies for Enhancing Dynamic Therapy
NewsJan 25, 2026

Nanoengineering‐Based Strategies for Enhancing Dynamic Therapy

Dynamic therapy, a ROS‑driven cancer treatment, is gaining traction for its high efficacy and low systemic toxicity. Recent nanoengineering advances focus on redesigning sensitizer nanostructures, deploying sophisticated nanocarriers, and modulating the tumor microenvironment to boost reactive oxygen species production. The...

By Small (Wiley)
Glass Transition and Water Activity Impact Grain Powder Flow
NewsJan 25, 2026

Glass Transition and Water Activity Impact Grain Powder Flow

Recent research reveals that the glass transition temperature of grain powders is strongly influenced by water activity. Lower moisture levels raise the glass transition point, resulting in a more rigid, less cohesive powder structure. This shift improves flowability, reducing blockages...

By Bioengineer.org
StockWatch: Qiagen Shares Rebound on Report It Is Assessing Strategic Options
NewsJan 25, 2026

StockWatch: Qiagen Shares Rebound on Report It Is Assessing Strategic Options

Qiagen (QGEN) shares surged to the $55 range after Bloomberg reported the company is evaluating strategic options, including a possible sale. The stock jumped 17% on the news, marking its strongest week in three years. Analysts note the firm’s EV/EBITDA...

By GEN (Genetic Engineering & Biotechnology News)
Gender Disparities in Statin Use Among HIV Patients
NewsJan 25, 2026

Gender Disparities in Statin Use Among HIV Patients

A recent cohort study of over 12,000 people living with HIV revealed a pronounced gender gap in cardiovascular preventive care. Women were 30% less likely to be prescribed statins than men, even after adjusting for age, lipid levels, and comorbidities....

By Bioengineer.org
New Regimen Boosts DLBCL Treatment: BTK Inhibitors, Rituximab, Lenalidomide
NewsJan 25, 2026

New Regimen Boosts DLBCL Treatment: BTK Inhibitors, Rituximab, Lenalidomide

A Phase II multicenter trial introduced a three‑drug regimen—BTK inhibitor, rituximab, and lenalidomide—for relapsed/refractory diffuse large B‑cell lymphoma (DLBCL). The combination achieved a 78% overall response rate, with 45% complete remissions and a median progression‑free survival of 24 months. Safety...

By Bioengineer.org
Impaired Vasculogenesis in Stem Cells From SCI Patients
NewsJan 25, 2026

Impaired Vasculogenesis in Stem Cells From SCI Patients

The study published in *Angiogenesis* examined adipose‑derived stem cells (ADSCs) from chronic spinal cord injury (SCI) patients and found they possess markedly impaired vasculogenic capacity compared with healthy donor cells. In vitro assays revealed deficient capillary‑like network formation, linked to...

By Bioengineer.org
NT-proBNP Predicts Ventricular Arrhythmias in Non-Compaction
NewsJan 25, 2026

NT-proBNP Predicts Ventricular Arrhythmias in Non-Compaction

A recent clinical study found that plasma NT‑proBNP levels reliably predict ventricular arrhythmias in patients with left ventricular non‑compaction (LVNC). Researchers measured NT‑proBNP in 120 LVNC patients and identified a 300 pg/mL threshold that separated high‑risk from low‑risk individuals. The association...

By Bioengineer.org
Revolutionizing Corynebacterium Diphtheriae Strain Classification
NewsJan 25, 2026

Revolutionizing Corynebacterium Diphtheriae Strain Classification

A consortium of microbiologists has introduced a whole‑genome sequencing framework that overhauls the classification of Corynebacterium diphtheriae strains. The new system groups isolates into five phylogenetically distinct clades, replacing the legacy serotype scheme that has been in use for decades....

By Bioengineer.org
Streptococcus Agalactiae and L-Carnitine in Endometriosis
NewsJan 25, 2026

Streptococcus Agalactiae and L-Carnitine in Endometriosis

Researchers have identified a link between the pelvic bacterium Streptococcus agalactiae and heightened severity of endometriosis lesions. In parallel, L‑carnitine supplementation was shown to dampen inflammatory pathways and shrink lesions in pre‑clinical models. Combined antibiotic clearance of S. agalactiae and...

By Bioengineer.org
COVID-19 Policies and Unmet Medical Needs in Nigeria
NewsJan 25, 2026

COVID-19 Policies and Unmet Medical Needs in Nigeria

Nigeria’s COVID-19 response has unintentionally widened gaps in essential health services, leaving millions with unmet medical needs. Stringent lockdowns curtailed outpatient visits, while vaccine distribution lagged behind regional targets. The strain on public hospitals has forced patients to seek costly...

By Bioengineer.org
Uncovering Early Signs of Celiac Disease in Adults
NewsJan 25, 2026

Uncovering Early Signs of Celiac Disease in Adults

Researchers led by Cohen, Nemet, and Kirzhner conducted a large‑scale retrospective cohort study that identified subtle laboratory and clinical precursors of celiac disease in young adults. Elevated gluten‑specific antibodies and non‑specific symptoms such as fatigue, mood disturbances, and mild gastrointestinal...

By Bioengineer.org
Exploring Immune Cell Dynamics in Aplastic Anaemia
NewsJan 25, 2026

Exploring Immune Cell Dynamics in Aplastic Anaemia

A recent study applied single‑cell RNA sequencing to bone‑marrow samples from aplastic anaemia patients, revealing a complex immune landscape that drives marrow failure. The analysis identified expanded cytotoxic CD8⁺ T cells, a marked reduction in regulatory T cells, and clonal...

By Bioengineer.org
AKT1 Epigenetics Drive Metabolic Shift in Lipedema
NewsJan 25, 2026

AKT1 Epigenetics Drive Metabolic Shift in Lipedema

Researchers have uncovered that epigenetic modifications of the AKT1 gene drive a metabolic shift in lipedema‑affected adipose tissue. DNA methylation and histone acetylation patterns increase AKT1 activity, prompting enhanced glycolysis and lipid accumulation. The study links this molecular change to...

By Bioengineer.org
Benchmarking Polygenic Scores with PGS-Hub Platform
NewsJan 25, 2026

Benchmarking Polygenic Scores with PGS-Hub Platform

The PGS‑hub platform was launched to provide a standardized, open‑source environment for benchmarking polygenic risk scores across diverse cohorts. It aggregates over 200 GWAS summary statistics, offers reproducible pipelines, and integrates cloud‑based compute resources. Early adopters report faster validation cycles...

By Bioengineer.org
Epigenetic Changes in Acute Promyelocytic Leukemia Uncovered
NewsJan 25, 2026

Epigenetic Changes in Acute Promyelocytic Leukemia Uncovered

Researchers led by Zhong, Cordeddu and Gamboa‑Cedeno have produced the first comprehensive epigenomic map of acute promyelocytic leukemia (APL), pinpointing disease‑specific deregulation of enhancers, transposable elements and Polycomb‑targeted genes. The study shows how mis‑wired enhancer networks, activated transposons and silenced...

By Bioengineer.org
CT Angiography Vs. Duplex: Evaluating Carotid Stenosis Flow
NewsJan 25, 2026

CT Angiography Vs. Duplex: Evaluating Carotid Stenosis Flow

A recent study published in 3D Print Med compared CT angiography with duplex sonography using a hemodynamic phantom that simulates carotid stenosis. The research demonstrated that CT angiography delivers high‑resolution three‑dimensional anatomical detail, whereas duplex sonography excels at real‑time blood‑flow measurement. Discrepancies between...

By Bioengineer.org
Mineral Supplements and Insulin Resistance in PCOS: Meta-Analysis
NewsJan 25, 2026

Mineral Supplements and Insulin Resistance in PCOS: Meta-Analysis

A new meta‑analysis of 12 randomized controlled trials involving 1,045 women with polycystic ovary syndrome evaluated the effect of mineral supplementation on insulin resistance. The pooled data showed that magnesium supplementation reduced HOMA‑IR by an average of 0.48 units (p < 0.01),...

By Bioengineer.org
Proteoglycans: Key Players in Vascular Development
NewsJan 24, 2026

Proteoglycans: Key Players in Vascular Development

Proteoglycans, the carbohydrate‑rich components of the extracellular matrix, have emerged as central regulators of vascular development. Recent studies demonstrate that heparan sulfate chains on proteoglycans bind and present angiogenic growth factors such as VEGF and FGF, directing endothelial cell proliferation...

By Bioengineer.org
AI Reveals Prognostic Insights in Colorectal Cancer
NewsJan 24, 2026

AI Reveals Prognostic Insights in Colorectal Cancer

Researchers have created an AI model that automatically quantifies the tumor‑stroma ratio (TSR) in colorectal cancer histology slides. The study demonstrates that a high TSR predicts poorer patient outcomes and uncovers stromal‑driven immune evasion. Validation across diverse international cohorts confirms...

By Bioengineer.org
New Biomarkers in Anti-TIF1-Γ Dermatomyositis Cancer Risk
NewsJan 24, 2026

New Biomarkers in Anti-TIF1-Γ Dermatomyositis Cancer Risk

A new study by Koumprentziotis et al. identifies anti‑TIF1‑γ antibodies as a powerful biomarker for cancer risk in patients with dermatomyositis. The research shows a markedly higher prevalence of malignancies among anti‑TIF1‑γ‑positive individuals compared with antibody‑negative counterparts. By integrating serological testing...

By Bioengineer.org